BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $6,425,000 | +6.1% | 82,309 | -13.7% | 3.01% | +11.0% |
Q2 2018 | $6,053,000 | -39.8% | 95,352 | -13.0% | 2.71% | -41.7% |
Q1 2018 | $10,055,000 | -1.7% | 109,652 | -19.1% | 4.66% | -0.1% |
Q4 2017 | $10,224,000 | -14.6% | 135,585 | -21.1% | 4.66% | -9.3% |
Q3 2017 | $11,971,000 | -22.2% | 171,822 | -43.4% | 5.14% | -28.4% |
Q2 2017 | $15,385,000 | -21.9% | 303,641 | -38.3% | 7.18% | -27.6% |
Q1 2017 | $19,689,000 | +0.1% | 492,341 | -29.8% | 9.92% | -6.7% |
Q4 2016 | $19,663,000 | – | 700,991 | – | 10.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |